Evidence map›Paper›PMID 36146453›Full record

ArticleVaccines2022

Incidence of Hospitalisation and Emergency Department Visits for Pneumococcal Disease in Children, Adolescents, and Adults in Liguria, Italy: A Retrospective Analysis from 2012-2018.

Matteo Astengo, Chiara Paganino, Daniela Amicizia, Laura Sticchi, Andrea Orsi, Giancarlo Icardi, Maria Francesca Piazza, Salini Mohanty, Francesca Senese, Gian Marco Prandi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. [The new 15-valent pneumococcal conjugate vaccine for the prevention ofJournal of preventive medicine and hygiene · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Matteo AstengoRegional Health Agency of Liguria (ALiSa), Piazza della Vittoria 15, 16121 Genoa, Italy.ORCID 0000-0003-4683-1945
Chiara PaganinoRegional Health Agency of Liguria (ALiSa), Piazza della Vittoria 15, 16121 Genoa, Italy.
Daniela AmiciziaRegional Health Agency of Liguria (ALiSa), Piazza della Vittoria 15, 16121 Genoa, Italy.ORCID 0000-0002-9707-5214
Laura SticchiDepartment of Health's Science (DiSSal), University of Genoa, 16132 Genoa, Italy.
Andrea OrsiDepartment of Health's Science (DiSSal), University of Genoa, 16132 Genoa, Italy.ORCID 0000-0002-2433-9610
Giancarlo IcardiDepartment of Health's Science (DiSSal), University of Genoa, 16132 Genoa, Italy.ORCID 0000-0002-8463-8487
Maria Francesca PiazzaRegional Health Agency of Liguria (ALiSa), Piazza della Vittoria 15, 16121 Genoa, Italy.ORCID 0000-0002-2404-3609
Salini MohantyMerck & Co., Inc., 126 East Lincoln Ave., P.O. Box 2000, Rahway, NJ 07065, USA.
Francesca SeneseMSD Italy, Via Vitorchiano 151, 00189 Rome, Italy.
Gian Marco PrandiMSD Italy, Via Vitorchiano 151, 00189 Rome, Italy.
Filippo AnsaldiRegional Health Agency of Liguria (ALiSa), Piazza della Vittoria 15, 16121 Genoa, Italy.
Agenzia Regionale per la Protezione dell'ambiente ligure · ITOspedale Policlinico San Martino · ITMSD (Italy) · ITMerck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

Merck Sharp & Dohme LLC NA
6 · The paper itself

Abstract

Streptococcus pneumoniae infection is responsible for significant morbidity and mortality, particularly in young children and older adults. The aim of this study was to investigate the incidence of hospitalisation and emergency department (ED) visits in relation to episodes of pneumococcal disease (PD) following the introduction of pneumococcal conjugate vaccines (PCVs) into the Liguria region of Italy. Between 2012 and 2018, episodes of all-cause pneumonia (80,152), pneumococcal-specific pneumonia (1254), unspecified pneumonia (66,293), acute otitis media (AOM; 17,040), and invasive PD (IPD; 1788) were identified from in-patient claims, ED and hospital discharge records, and the Liguria Chronic Condition Data Warehouse. In children < 15 years of age, pneumococcal pneumonia-related hospitalisations decreased from 35 to 13 per 100,000 person-years during the study period (p < 0.001); this decrease is potentially related to PCV use in children. All-cause pneumonia hospitalisations remained stable, whereas IPD hospitalisations increased and AOM hospitalisations decreased. In adults, hospitalisations for all-cause pneumonia increased from 5.00 to 7.50 per 1000 person-years (+50%; p < 0.001). Pneumococcal and unspecified pneumonia hospital admissions increased significantly during the study period, considerably affecting those ≥ 65 years of age. IPD hospitalisations varied across all age groups, but a significant change was not observed. Despite pneumococcal vaccination, substantial burden remains for PD in children and adults in Liguria, Italy.

Indexed as

adolescentsadultschildrenIPDItalypneumococcal diseasepneumonia

Identifiers

PMID36146453
PMCPMC9504569
OpenAlexW4293169169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.